BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1533038)

  • 1. [Nodular efflorescence and cutaneous vasculitis in rheumatoid arthritis treated with methotrexate].
    Lassoued S; Billey T; Pages M; Dromer C; Fournie B; Fournie A
    Presse Med; 1992 Mar; 21(9):437. PubMed ID: 1533038
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous necrotizing vasculitis after low dose methotrexate therapy for rheumatoid arthritis: a possible manifestation of methotrexate hypersensitivity.
    Simonart T; Durez P; Margaux J; Van Geertruyden J; Goldschmidt D; Parent D
    Clin Rheumatol; 1997 Nov; 16(6):623-5. PubMed ID: 9456017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate related cutaneous vasculitis.
    Torner O; Ruber C; Olive A; Tena X
    Clin Rheumatol; 1997 Jan; 16(1):108-9. PubMed ID: 9132315
    [No Abstract]   [Full Text] [Related]  

  • 4. Leukocytoclastic vasculitis induced by low-dose methotrexate: in vitro evidence for an immunologic mechanism.
    Halevy S; Giryes H; Avinoach I; Livni E; Sukenik S
    J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):81-5. PubMed ID: 9552765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous vasculitis associated with infliximab in the treatment of rheumatoid arthritis.
    Anandacoomarasamy A; Kannangara S; Barnsley L
    Intern Med J; 2005 Oct; 35(10):638-40. PubMed ID: 16207269
    [No Abstract]   [Full Text] [Related]  

  • 6. Leukocytoclastic vasculitis associated with methotrexate therapy.
    Düzova A; Soysal A; Ozen S; Akyüz C; Gököz A; Yetgin S
    Turk J Pediatr; 2000; 42(3):267-8. PubMed ID: 11105634
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-dose methotrexate therapy for cutaneous vasculitis of rheumatoid arthritis.
    Upchurch KS; Heller K; Bress NM
    J Am Acad Dermatol; 1987 Aug; 17(2 Pt 2):355-9. PubMed ID: 3624579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Clemente RE
    Scand J Rheumatol; 2007; 36(3):244-5; author reply 245. PubMed ID: 17657687
    [No Abstract]   [Full Text] [Related]  

  • 9. Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis.
    Sakaue S; Sumitomo S; Kubo K; Fujio K; Yamamoto K
    Rheumatology (Oxford); 2014 Aug; 53(8):1529-30. PubMed ID: 24609062
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukocytoclastic Vasculitis and Dermal Perivascular Hemophagocytosis Associated With Adalimumab Therapy for Rheumatoid Arthritis.
    Muto J; Usami J; Watanabe D
    Am J Dermatopathol; 2018 Jan; 40(1):57-59. PubMed ID: 28719435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocytoclastic vasculitis due to etanercept.
    Galaria NA; Werth VP; Schumacher HR
    J Rheumatol; 2000 Aug; 27(8):2041-4. PubMed ID: 10955351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasculitis occurring during leflunomide therapy.
    Holm EA; Balslev E; Jemec GB
    Dermatology; 2001; 203(3):258-9. PubMed ID: 11701983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leflunomide for active rheumatoid arthritis.
    Bruyn GA; Griep EN; Korff KJ
    Lancet; 1999 May; 353(9167):1883; author reply 1883-4. PubMed ID: 10359439
    [No Abstract]   [Full Text] [Related]  

  • 14. Rheumatoid nodules located in the penis of a methotrexate-treated patient with rheumatoid arthritis.
    Essig KM; Mayet WJ; Mottrie AM; Helmreich-Becker I; Meyer zum Büschenfelde KH
    Z Rheumatol; 1994; 53(5):314-6. PubMed ID: 7810240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous vasculitis induced by TNF inhibitors: a report of three cases.
    Fujikawa K; Kawakami A; Hayashi T; Iwamoto N; Kawashiri SY; Aramaki T; Ichinose K; Tamai M; Arima K; Kamachi M; Yamasaki S; Nakamura H; Ida H; Origuchi T; Eguchi K
    Mod Rheumatol; 2010 Feb; 20(1):86-9. PubMed ID: 19812889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous vasculitis after intermediate dose of methotrexate (IDMTX).
    Fondevila Carlos G; Milone Gustavo A; Santiago P
    Br J Haematol; 1989 Aug; 72(4):591-2. PubMed ID: 2775662
    [No Abstract]   [Full Text] [Related]  

  • 17. The frequency of cutaneous vasculitis is not increased in patients with rheumatoid arthritis treated with methotrexate.
    Kaye O; Beckers CC; Paquet P; Arrese JE; Piérard GE; Malaise MG
    J Rheumatol; 1996 Feb; 23(2):253-7. PubMed ID: 8882028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eruption of nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis.
    Jeurissen ME; Boerbooms AM; van de Putte LB
    Clin Rheumatol; 1989 Sep; 8(3):417-9. PubMed ID: 2805620
    [No Abstract]   [Full Text] [Related]  

  • 19. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Martínez-Taboada VM; Val-Bernal JF; Pesquera LC; Fernández-Llanio NE; Esteban JM; Blanco R; Alonso-Bartolome P; Gonzalez-Vela C; Rodríguez-Valverde V
    Scand J Rheumatol; 2006; 35(4):322-3. PubMed ID: 16882599
    [No Abstract]   [Full Text] [Related]  

  • 20. Rituximab-induced vasculitis: A case report and review of the medical published work.
    Kim MJ; Kim HO; Kim HY; Park YM
    J Dermatol; 2009 May; 36(5):284-7. PubMed ID: 19382999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.